Treatment of Sézary syndrome with cyclosporin A.
作者信息
Puttick L, Pollock A, Fairburn E
出版信息
J R Soc Med. 1983 Dec;76(12):1063-5. doi: 10.1177/014107688307601216.
Abstract
摘要
相似文献
1
Treatment of Sézary syndrome with cyclosporin A.用环孢菌素A治疗塞扎里综合征。
J R Soc Med. 1983 Dec;76(12):1063-5. doi: 10.1177/014107688307601216.
2
[Use of cyclosporin A in the treatment of Sezary's syndrome].
Pol Tyg Lek. 1990;45(21-22):444-5.
3
Sézary syndrome: transformation to a high grade T-cell lymphoma after treatment with Cyclosporin A.塞扎里综合征：环孢素A治疗后转化为高级别T细胞淋巴瘤。
Clin Exp Dermatol. 1983 Mar;8(2):159-69. doi: 10.1111/j.1365-2230.1983.tb01760.x.
4
Remission of Sézary's syndrome with cyclosporin A. Mild capillary leak syndrome as an unusual side effect.环孢素A治疗Sezary综合征缓解。轻度毛细血管渗漏综合征作为一种不寻常的副作用。
Acta Derm Venereol. 1986;66(1):80-2.
5
[Cyclosporin A: a new immunosuppressive peptide].[环孢菌素A：一种新型免疫抑制肽]
Sheng Li Ke Xue Jin Zhan. 1985 Jan;16(1):41-4.
6
Treatment of therapy-resistant Sézary syndrome with Cyclosporin-A: suppression of pruritus, leukaemic T cell activation markers and tumour mass.
Scand J Haematol. 1985 Feb;34(2):196-203. doi: 10.1111/j.1600-0609.1985.tb02256.x.
7
Cyclosporine in the treatment of cutaneous T cell lymphoma.
J Am Acad Dermatol. 1990 Dec;23(6 Pt 1):1084-9. doi: 10.1016/0190-9622(90)70337-h.
8
Cyclosporin A.环孢素A
J Am Acad Dermatol. 1986 May;14(5 Pt 1):785-91. doi: 10.1016/s0190-9622(86)70094-7.
9
Dermatological aspects of the use of Cyclosporin A for prophylaxis of graft-versus-host disease.环孢素A用于预防移植物抗宿主病的皮肤学方面。
Br J Dermatol. 1984 Apr;110(4):469-74. doi: 10.1111/j.1365-2133.1984.tb04662.x.
10
Effects of levamisole in Sézary syndrome. Apparent acceleration of disease.左旋咪唑对塞扎里综合征的影响。疾病的明显加速。
Dermatologica. 1979;159(6):461-5. doi: 10.1159/000250657.
引用本文的文献
1
Cyclosporin A enhances locoregional metastasis of the CC531 rat colon tumour.环孢素A增强CC531大鼠结肠肿瘤的局部区域转移。
J Cancer Res Clin Oncol. 1997;123(1):21-4. doi: 10.1007/BF01212610.
2
Growth inhibition of human gastrointestinal cancer cells by cyclosporin A.环孢素A对人胃肠道癌细胞的生长抑制作用
J Cancer Res Clin Oncol. 1994;120(12):695-9. doi: 10.1007/BF01194265.
3
Effects of cyclosporin A and a non-immunosuppressive analogue, O-acetyl cyclosporin A, upon the growth of parent and multidrug resistant human lung cancer cells in vitro.环孢素A及一种非免疫抑制类似物O-乙酰环孢素A对亲本及多药耐药人肺癌细胞体外生长的影响。
Br J Cancer. 1992 Mar;65(3):335-40. doi: 10.1038/bjc.1992.68.
本文引用的文献
1
Pathological changes developing in the rat during a 3-week course of high dosage cyclosporin A and their reversal following drug withdrawal.大鼠在高剂量环孢素A为期3周的疗程中出现的病理变化及其停药后的逆转情况。
Transplantation. 1981 Oct;32(4):271-7. doi: 10.1097/00007890-198110000-00002.
2
Cyclosporin-A is selectively cytotoxic to human leukemic T cells in vitro.环孢菌素A在体外对人白血病T细胞具有选择性细胞毒性。
Blood. 1982 May;59(5):1103-7.
3
Cyclosporin A blocks receptors for HLA-DR antigens on T cells.环孢素A可阻断T细胞上HLA - DR抗原的受体。
Nature. 1981 Apr 30;290(5809):792-4. doi: 10.1038/290792a0.
4
Cyclosporin A.环孢素A
Transplantation. 1981 Nov;32(5):349-54.
5
Antiproliferative activity of cyclosporin A on human T-lymphoblastic leukaemia cell line.环孢素A对人T淋巴细胞白血病细胞系的抗增殖活性。
Lancet. 1981 Apr 11;1(8224):838. doi: 10.1016/s0140-6736(81)92712-4.
6
Nephrotoxicity of cyclosporin A in liver and kidney transplant patients.环孢素A在肝肾移植患者中的肾毒性
Lancet. 1981 Feb 28;1(8218):470-1. doi: 10.1016/s0140-6736(81)91851-1.
7
Mycosis fungoides. Survival, prognostic features, response to therapy, and autopsy findings.蕈样肉芽肿。生存率、预后特征、对治疗的反应及尸检结果。
Medicine (Baltimore). 1972 Jan;51(1):61-72.
8
Erythroderma with atypical lymphocytes. (Sézary syndrome).伴有非典型淋巴细胞的红皮病。（塞扎里综合征）
Am J Med. 1973 Aug;55(2):192-8. doi: 10.1016/0002-9343(73)90168-x.
9
Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers.环孢素A最初作为唯一的免疫抑制剂应用于34例尸体器官接受者：32例肾移植、2例胰腺移植和2例肝移植。
Lancet. 1979 Nov 17;2(8151):1033-6. doi: 10.1016/s0140-6736(79)92440-1.
10
Cyclosporin A for the treatment of graft-versus-host disease in man.环孢素A用于治疗人类移植物抗宿主病。
Lancet. 1978;2(8104-5):1327-31. doi: 10.1016/s0140-6736(78)91971-2.
Zotero 插件